What would be interesting to see, is if there is a

Quote:

---

What would be interesting to see, is if there is any kind of clause in their agreement with Vyera which would allow them to void the deal under certain circumstances while allowing them to keep the money they already received, which, and this is just a thought, COULD open the door to a clean buyout if some BP were so inclined.

Read More: https://investorshangout.com/post/newpost/605...z6CH6WNLJ9

---

This was my first thought. I've always thought Vyera might not be who ends up selling leronlimab at the end of the day, and this just fuels that line of thinking. Part of my rationale has always been that a BP may just make Vyera a nice cash/royalties offer to get out of the way to facilitate a clean deal, be it licensing (more likely, in my opinion) or buyout. I think that this scenario just got more realistic.